---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-110429"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2024-12-19T23:59:59+00:00"
generated_at: "2026-05-29T01:43:25.140221+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# InMed director Janet Grove fails re-election; resignation tendered per majority voting policy

## Summary
- Janet Grove received only 44.26% votes for (55.74% withheld); per policy she tendered resignation to Board chair.
- Nominating & Governance Committee will review whether to accept Grove's resignation; update to follow.
- Four other director nominees re-elected with >96% votes for each (Adams, Hull, Lemerond, Baldasare).
- Shareholders approved appointment of Marcum LLP (now CBIZ LLP) as independent auditor for the next year.

## SEC filing metadata
- accession: 0001213900-24-110429
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2024-12-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390024110429/0001213900-24-110429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390024110429/ea0225311-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-110429
- JSON: https://secwatch.observer/filing/0001213900-24-110429.json
- Plain text: https://secwatch.observer/filing/0001213900-24-110429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.